VIA PHARMACEUTICALS, INC. (VIAP)
Clinical trial NCT06717308 updates: 1. completion date: 2026-09-15 → 2027-03-31 2. primary completion date: 2026-08-31 → 2027-02-28
Clinical trial NCT06717308 updates: 1. completion date: 2026-09-15 → 2027-03-31 2. primary completion date: 2026-08-31 → 2027-02-28
📈 **POSITIVE** • Low confidence analysis (52%) • Moderate positive clinical data • Good growth prospects **Sentiment:** Positive (55%) **Content type:** Clinical